Korean Journal of Clinical Pharmacy (한국임상약학회지)

Korean College Of Clinical Pharmacy (한국임상약학회)
권호 표지
DOI QR코드

DOI QR Code

Exploring the Perception on Drug Utilization Review System and DUR Modernization Pilot Project: A Qualitative Study Using Focus Group Interviews

DUR 제도 및 DUR 고도화 시범사업에 대한 인식 탐구: 포커스 그룹 인터뷰 기법 중심의 질적 연구

  • 배성호 (성균관대학교 약학대학) ;
  • 전하림 (성균관대학교 약학대학) ;
  • 윤동원 (성균관대학교 약학대학) ;
  • 최아형 (성균관대학교 약학대학) ;
  • 이혜성 (성균관대학교 약학대학) ;
  • 신주영 (성균관대학교 약학대학)
  • Received : 2021.03.09
  • Accepted : 2021.04.08
  • Published : 2021.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objective: To explore the perception of drug utilization review (DUR) system and DUR modernization pilot project among healthcare professionals and patients. Methods: We conducted 8 times of focus group interviews (FGI) between August 1, 2019 to December 31, 2019. The healthcare professionals and patients who participated in the DUR modernization pilot project were included in the present study. Based on the type of project participation or medical institution, the participants were divided into the following four groups: group 1, hospital; group 2, clinic; group 3, pharmacy; and group 4, patient. Within each group, interviews were conducted under a pre-defined agenda to identify the implicit perceptions of the participants; the contents of the interviews were, then, categorized. Results: Healthcare professionals established a consensus on the positive aspects of the DUR system and DUR modernization pilot project. However, substantial concerns remain, such as additional workload associated with monitoring adverse events or acquiring consents from patients. Furthermore, a difference of opinion over the DUR convenience system was observed. Among 3 DUR convenience system, the personal medication history review service was highly utilized, but pop-up hold function and communication system was rarely used. Conclusion: We observed that systematic intervention using the DUR system is effective for both healthcare providers and consumers. Adverse events caused by inappropriate drug use can be prevented by continuous patient monitoring. Therefore, the role of DUR system needs to be expanded to establish a safe drug management system.

Keywords

Acknowledgement

이 논문은 2020년도 건강보험심사평가원의 지원을 받아 수행한 DUR 고도화 시범사업 평가연구 용역 결과를 토대로 작성되었으며, 건강보험심사평가원의 공식적인 견해와는 다를 수 있다.

References

  1. World Health Organization. WHO Pharmacovigilance Indicators: A Practical Manual For the Assessment of Pharmacovigilance Systems. Available from https://apps.who.int/iris/handle/10665/186642. Accessed Februrary 03, 2021.
  2. World Health Organization. WHO Global Patient Safety Challenge: Medication Without Harm. Available from https://www.who.int/patientsafety/medication-safety/en/. Accessed Februrary 06, 2021
  3. Jung DG. Achievements and chanllenges of Drug Utilization Review system. HIRA Research 2019;13(2):12-21
  4. Kim DS, Jeon HL, Park JH. Drug Utilization Review system Implementation Plan for Medication Use in Geriatrics. Health Insurance Review & Assessment Service (HIRA); 2014. 105p.
  5. Park BJ, Shin JY, Shin SM, et al. Long-term research plan for strategic development of DUR Information. Korea Institute of Drug Safety and Risk Management (KIDS); 2014. 145p
  6. Koo BK, Shin JY, Kim MJ, et al. Retrospective drug utilization review on medicine abuse and DUR contraindicated medicines. Korea Institute of Drug Safety and Risk Management (KIDS); 2015. 353p
  7. Kim DS, Byun JH, Cho DY, Shin HR, Kim BS, Kim MJ, et al. Establishing the basis for retrospective analysis of drug adverse effects and monitoring system. Health Insurance Review & Assessment Service (HIRA); 2018. 276p
  8. Health Insurance Review & Assessment Service (HIRA). Establishment of patient safety platform through drug use monitoring system. Available from https://www.hira.or.kr/bbsDummy.do?pgmid=HIRAA020041000100&brdScnBltNo=4&brdBltNo=9859. Assessed Februrary 07, 2021.
  9. Song JE, Chae HJ, Park BL. Experiences of Sanhujori facility use among the first time mother by the focus group interview. Korean J Women Health Nurs 2015;21(3):184-96. https://doi.org/10.4069/kjwhn.2015.21.3.184
  10. Kitzinger J. Qualitative Research: Introducing focus groups. BMJ 1995;311:299. https://doi.org/10.1136/bmj.311.7000.299
  11. Lee SS, Kim AH. Teachers' perception of learning disabilities: A focus group study with general and special education teachers. Journal of Special Education 2008;20:113-37. https://doi.org/10.19049/jsped.2019.20.3.07
  12. Bengtsson M. How to plan and perform a qualitative study using content analysis. NursingPlus Open 2016;2:8-14. https://doi.org/10.1016/j.npls.2016.01.001
  13. Organisation for Economic Co-operation and Development (OECD). Health Care Resources. 2020. Available from https://stats.oecd.org/Index.aspx?DataSetCode=HEALTH_REAC. Accessed Feb 01, 2021.
  14. Lee CH, Lim HS, Kim YN, et al. Analysis of new patient's willingness to pay additional costs for securing satisfactory consultation time. Health policy and management 2017;27(1):39-46. https://doi.org/10.4332/KJHPA.2017.27.1.39
  15. World Health Organization. WHO High 5s: Standaed Operating Procedures, 2014. Available from https://www.who.int/initiatives/high-5s-standard-operating-procedures. Accessed Feb 09, 2021.
  16. Baseman JG, Revere D, Painter I, Toyoji M, Thiede H, Duchin J. Public health communications and alert fatigue. BMC Health Serv Res 2013;13:295. https://doi.org/10.1186/1472-6963-13-295
  17. Stevenson FA, Barry CA, Britten N, Barber N, Bradley CP. Doctor-patient communication about drugs: the evidence for shared decision making. Soc Sci Med 2000;50(6):829-40. https://doi.org/10.1016/S0277-9536(99)00376-7